Acute Asthma Exacerbation Management

Clinical Assessment and Treatment

• A respiratory rate of 35/min exceeds the threshold of >25/min for severe asthma, indicating the need for immediate intervention, according to the British Thoracic Society 1, 2
• Lack of response to two doses of albuterol within 24 hours signals treatment failure, requiring escalation of care, as recommended by the British Thoracic Society 1, 2
• Wheezing in all lung fields with recent viral upper respiratory symptoms suggests viral-triggered exacerbation, which is a common trigger for asthma exacerbations in this age group, according to the American Academy of Allergy, Asthma, and Immunology 3

Immediate Treatment Protocol

• Systemic corticosteroids should be given immediately upon recognition of acute severe asthma, not delayed, to address the underlying airway inflammation, as recommended by the British Thoracic Society 1, 2
• The addition of ipratropium to beta-agonist therapy is specifically indicated when initial beta-agonist treatment fails, providing additional bronchodilation through a different mechanism of action, according to the British Thoracic Society 1, 2

Rationale for This Approach

• Viral respiratory infections are the most common trigger for asthma exacerbations in this age group, and the patient's symptoms strongly suggest viral-induced bronchospasm, according to the American Academy of Allergy, Asthma, and Immunology 3

Common Pitfalls to Avoid

• Do not delay systemic corticosteroids while continuing to give repeated doses of albuterol alone, as this patient has already failed two doses, indicating the need for escalation, as recommended by the British Thoracic Society 1, 2
• Do not use antibiotics unless bacterial infection is confirmed, as this patient's clear rhinorrhea and viral prodrome do not suggest bacterial infection, according to the British Thoracic Society 2

Disposition and Follow-Up

• Criteria for hospital admission include persistent features of severe asthma after initial treatment, peak expiratory flow remaining <50% predicted 15-30 minutes after nebulization, and afternoon or evening presentation, as recommended by the British Thoracic Society 1, 2
• Prescription of inhaled corticosteroids is recommended if not already on controller therapy, according to the American Academy of Allergy, Asthma, and Immunology 3

Acute Asthma Management in Children

Recognition and Initial Treatment

• For acute severe asthma exacerbations in children, the American Thoracic Society recommends immediately administering high-flow oxygen, nebulized salbutamol, intravenous hydrocortisone, and adding ipratropium, with prednisolone for ongoing management 4, 5
• Identify children requiring immediate aggressive treatment by clinical features such as being too breathless to talk or feed, respiratory rate >50 breaths/minute, pulse >140 beats/minute, and peak expiratory flow <50% predicted 4, 5

Immediate Treatment Protocol

• Administer intravenous hydrocortisone immediately, high-flow oxygen via face mask to maintain SaO₂ >92%, and nebulized salbutamol 5 mg or terbutaline 10 mg via oxygen-driven nebulizer 4, 5, 6
• Add ipratropium 100 mcg nebulized every 6 hours 4, 5, 6

Monitoring and Subsequent Management

• Repeat peak expiratory flow measurement 15-30 minutes after starting treatment, maintain oximetry SaO₂ >92%, and chart PEF before and after β-agonist administration at least 4 times daily 4, 5, 6
• If the patient is improving, continue high-flow oxygen, prednisolone 1-2 mg/kg daily, and nebulized β-agonist 4 hourly 4, 5, 6

Discharge Criteria and Follow-Up

• Children should meet all discharge criteria, including being on discharge medication for 24 hours, PEF >75% of predicted, and treatment with soluble steroid tablets and inhaled steroids in addition to bronchodilators 4, 5, 6
• Arrange GP follow-up within 1 week and follow-up appointment in respiratory clinic within 4 weeks 4, 5, 6

Home Management of Yellow Zone Symptoms

• Administer 4-8 puffs of salbutamol via MDI with spacer every 20 minutes for up to 3 doses, and start oral prednisone 1-2 mg/kg immediately when yellow zone symptoms appear 7
• Reassess the child 15-30 minutes after each bronchodilator dose, and seek immediate medical care if the child cannot complete sentences in one breath, pulse >110 bpm or respiratory rate >25/minute persists, or the child appears exhausted, drowsy, or confused 7

Management of Asthma Exacerbation in Children

Initial Assessment and Treatment

• The American Thoracic Society recommends using a metered-dose inhaler (MDI) with a large volume spacer as the preferred delivery device for children, as it is equally effective to nebulization and may result in lower admission rates, particularly in more severe exacerbations, with fewer cardiovascular side effects 8, 9, 10
• The use of MDI with spacer is recommended for children aged 7 years, as most children cannot achieve the coordination necessary for unmodified MDI use, and proper inhaler technique and age-appropriate device should be ensured before escalating therapy 8, 9, 10

Ongoing Management

• Relief treatment can be repeated 2-4 hourly at home, but failure to respond or early deterioration requires immediate medical assessment, and proper inhaler technique and age-appropriate device should be ensured before escalating therapy 8, 9, 10
• A written action plan should be provided for parents detailing when to increase bronchodilators and when to seek immediate care, to ensure proper management of asthma exacerbations 8, 9, 10

Initial Management of Asthma Exacerbation

Immediate Recognition and Treatment

• The British Thoracic Society recommends immediate administration of high-flow oxygen via face mask, nebulized salbutamol 5 mg, oral prednisolone 1-2 mg/kg, and ipratropium 100 mcg to the nebulizer in a child with asthma exacerbation 11
• High-flow oxygen via face mask should be administered to maintain oxygen saturation >92% in a child with asthma exacerbation 11
• Salbutamol 5 mg via oxygen-driven nebulizer or 5 mg via MDI with large volume spacer should be given to a child with asthma exacerbation 11
• Oral prednisolone 1-2 mg/kg should be administered as a single dose to a child with asthma exacerbation 11
• Ipratropium 100 mcg should be added to the nebulizer immediately and repeated every 6 hours in a child with asthma exacerbation 11
• The use of an MDI with a large volume spacer is equally effective to nebulization and may result in lower admission rates in children with asthma exacerbation 11, 12

Assessment of Severity

• Features indicating severe exacerbation in a child include being too breathless to talk or feed, respiratory rate >50 breaths/minute, pulse >140 beats/minute, and peak expiratory flow <50% predicted 11
• Life-threatening features in a child with asthma exacerbation include peak flow <33% predicted, poor respiratory effort, silent chest, cyanosis, exhaustion, altered level of consciousness, or agitation 11

Monitoring and Reassessment

• Repeat assessment should be done 15-30 minutes after starting treatment in a child with asthma exacerbation 11
• Peak expiratory flow should be measured before and after each bronchodilator dose in a child with asthma exacerbation 11
• Continuous pulse oximetry should be maintained with a target >92% in a child with asthma exacerbation 11

Hospital Admission Criteria

• A child with asthma exacerbation should be admitted to the hospital if they fail to respond to initial treatment, have peak expiratory flow <50% predicted, or have persistent features of severe asthma 11, 13
• Admission is also recommended if the parents are unable to give appropriate treatment at home or if the general practitioner requests admission 13

Discharge Criteria

• A child with asthma exacerbation can be discharged if they have been on discharge medication for 24 hours, have a peak flow >75% of predicted, and have treatment that includes oral steroids and inhaled steroids in addition to bronchodilators 11
• A written action plan and follow-up with the GP and respiratory clinic are also recommended before discharge 11

Hydrocortisone Dosage for Pediatric Asthma

Immediate Treatment Protocol

• The American Academy of Allergy, Asthma, and Immunology recommends oral corticosteroids as the preferred route when the child can swallow and has no vomiting, as there is no advantage to intravenous administration when gastrointestinal transit is normal 14, 15
• Intravenous hydrocortisone is reserved for children who are vomiting, seriously ill, or unable to take oral medications 14, 16

Specific Dosing Regimens

• The American Thoracic Society suggests intravenous hydrocortisone 200 mg every 6 hours for children requiring IV therapy 16
• Alternative weight-based dosing is 4 mg/kg/dose every 6 hours, though the 200 mg fixed dose is more commonly cited in guidelines 16
• The American Academy of Pediatrics recommends oral corticosteroids, such as prednisolone or prednisone, at a dose of 1-2 mg/kg/day in 2 divided doses, with a maximum of 60 mg/day 14, 15

Treatment Algorithm

• The American College of Allergy, Asthma, and Immunology advises giving oral prednisolone 1-2 mg/kg (max 60 mg) immediately if the child can swallow and is not vomiting 14
• If the child is vomiting, seriously ill, or unable to take oral medications, give IV hydrocortisone 200 mg 16

Age-Specific Considerations

• The American Academy of Pediatrics states that the 1-2 mg/kg/day oral dosing (max 60 mg/day) applies across all pediatric age groups 14, 15
• Updated guidelines specifically increased the maximum from 30 mg to 60 mg for children 0-4 years 14, 15

Concurrent Therapy

• The American Thoracic Society recommends combining systemic corticosteroids with high-dose inhaled beta-2 agonists (salbutamol/albuterol) 16

Salbutamol Dosing for Acute Asthma Exacerbation in Pediatric Patients

Delivery Method Selection

• The European Respiratory Society recommends administering salbutamol 2.5 mg (age ≤2 years) or 5.0 mg (age >2 years) via nebulizer every 20 minutes for up to 3 doses in the first hour, or alternatively 4-8 puffs via MDI with spacer every 20 minutes for 3 doses 17
• MDI with large volume spacer is strongly recommended by all major guidelines and may result in lower admission rates, particularly in more severe exacerbations, with fewer cardiovascular side effects 17

Dosing Variability Across Guidelines

• International guidelines show significant variability in salbutamol dosing recommendations, ranging from 2-10 puffs (200-1000 μg) via MDI-spacer, with timing administration ranging from 20-30 minutes for the first hour 17, 18

Concurrent Essential Therapy

• High-flow oxygen via face mask should be administered to maintain oxygen saturation >92% 17

Pediatric Asthma Emergency Treatment

Initial Management

• For pediatric asthma exacerbations, the American Academy of Allergy, Asthma, and Immunology recommends adding ipratropium bromide when initial albuterol treatment fails or for severe exacerbations, as the combination of beta-agonist plus ipratropium reduces hospitalizations, particularly in patients with severe airflow obstruction 19
• The American Academy of Allergy, Asthma, and Immunology suggests that in children with severe asthma, adding ipratropium to albuterol and corticosteroid therapy significantly decreases hospitalization rates 19

Reassessment and Monitoring

• The American Academy of Allergy, Asthma, and Immunology recommends repeat clinical assessment and PEF measurement 15-30 minutes after starting treatment, then after each set of bronchodilator doses, as response to treatment in the ED is a better predictor of hospitalization need than initial severity 19

Treatment Recommendations

• The American Academy of Allergy, Asthma, and Immunology advises against the use of antibiotics, aggressive hydration in older children, methylxanthines, chest physiotherapy, mucolytics, and sedation in the treatment of pediatric asthma exacerbations 19

Impending Respiratory Failure

• The American Academy of Allergy, Asthma, and Immunology recommends recognizing signs of impending respiratory failure early, such as inability to speak, altered mental status, intercostal retractions, worsening fatigue, and PaCO₂ ≥42 mm Hg, and considering IV magnesium sulfate for life-threatening exacerbations or those remaining severe after 1 hour of intensive conventional treatment 19

Immediate Management of Severe Pediatric Asthma Exacerbation

Recognition of Life-Threatening Severity

• The American Thoracic Society recommends that a respiratory rate of 40 breaths/min exceeds the threshold for severe asthma in children under 5 years, indicating life-threatening features 20
• The British Medical Journal suggests that an oxygen saturation of 88% represents severe hypoxemia requiring immediate intervention, as it is below the recommended threshold 20
• The use of accessory muscles indicates significant respiratory distress, according to the British Medical Journal 20

Immediate Treatment Protocol

• The British Medical Journal recommends administering 40-60% oxygen via face mask immediately to maintain SaO₂ >92% in patients with severe asthma exacerbation 20
• The British Medical Journal suggests adding ipratropium 100 mcg to the nebulizer immediately given failure of initial beta-agonist therapy, to improve bronchodilation 20
• The British Medical Journal recommends oral prednisolone 1-2 mg/kg (maximum 40 mg) immediately if the child can swallow and is not vomiting, as systemic corticosteroids are critical in severe asthma exacerbation 20
• The Thorax journal states that underuse of corticosteroids is specifically identified as a leading cause of preventable asthma mortality, emphasizing the importance of prompt administration 21

Monitoring and Reassessment

• The British Medical Journal recommends charting response to bronchodilator doses and maintaining continuous pulse oximetry with a target SaO₂ >92% to monitor treatment efficacy 20

Hospital Admission

• The Thorax journal suggests that hospital admission is required for patients with life-threatening features, such as severe hypoxemia, accessory muscle use, and failure to respond to initial albuterol therapy 21, 22

Critical Pitfalls to Avoid

• The British Medical Journal advises against delaying systemic corticosteroids while giving repeated albuterol doses alone, as this can worsen outcomes 20
• The British Medical Journal recommends against using sedatives of any kind in acute severe asthma, as they can depress respiratory function 20
• The British Medical Journal suggests that IV aminophylline should not be used as first-line therapy, but rather reserved for patients not improving after initial treatment 20

If Patient Fails to Improve After Initial Treatment

• The British Medical Journal recommends continuing oxygen and steroids, increasing nebulized bronchodilator frequency, and considering IV aminophylline if the patient fails to improve after initial treatment 20
• The British Medical Journal suggests transferring the patient to the ICU if they are deteriorating, have persistent hypoxemia, exhaustion, or altered consciousness 20

Management of Asthma Exacerbation in Children

Initial Treatment Protocol

• The European Respiratory Society recommends that MDI with spacer is equally effective to nebulization and may result in lower admission rates with fewer cardiovascular side effects in children with asthma exacerbation 23, 24
• High-flow oxygen via face mask should be administered to maintain saturation >92% in children with asthma exacerbation, as recommended by the American Academy of Allergy, Asthma, and Immunology 25

Workup and Monitoring

• Arterial blood gas and chest X-ray may be indicated in severe asthma exacerbation or inadequate response to treatment, according to the European Respiratory Society 23

Discharge Management and Follow-Up

• The American Academy of Allergy, Asthma, and Immunology recommends continuing oral prednisolone 1-2 mg/kg daily for 3-5 days after discharge in children with asthma exacerbation 25

Critical Pitfalls to Avoid

• The European Respiratory Society advises against delaying systemic corticosteroids while giving repeated albuterol doses alone, and against using antibiotics routinely in asthma exacerbation, unless bacterial infection is confirmed 24

Paramedic Asthma Treatment for Children

First-Line Bronchodilator Therapy

• Most children, such as a 5-year-old, cannot use an unmodified metered-dose inhaler (MDI) without a spacer device, highlighting the importance of proper technique 26

Critical Pitfalls to Avoid

• The American Academy of Allergy, Asthma, and Immunology recommends against using antibiotics unless bacterial infection is confirmed, as viral respiratory infections are the most common trigger in this age group 27
• Ensuring proper spacer technique is crucial, involving actuating the MDI, having the child breathe in one puff, and repeating until the appropriate number of puffs are inhaled, as recommended by the Thorax journal 26

Management of Acute Severe Asthma Exacerbations in Pediatric Patients

Initial Treatment and Ongoing Management

• The British Thoracic Society recommends decreasing the frequency of nebulizer treatments to every 4 hours as symptoms improve in pediatric patients with acute severe asthma exacerbations 28, 29
• The British Thoracic Society suggests adding ipratropium bromide to nebulizer treatment every 6 hours when initial beta-agonist treatment fails in pediatric patients with acute severe asthma exacerbations 28, 29

Critical Monitoring Parameters

• Life-threatening features requiring immediate escalation in pediatric patients with acute severe asthma exacerbations include silent chest or poor respiratory effort, cyanosis or oxygen saturation <92%, exhaustion, altered consciousness, or agitation, and respiratory rate >50/min or pulse >140/min in children 28

Essential Concurrent Therapy

• The British Thoracic Society recommends administering systemic corticosteroids immediately upon recognition of acute severe asthma in pediatric patients, with oral prednisolone 1-2 mg/kg (maximum 40-60 mg) or IV hydrocortisone 100 mg every 6 hours if unable to take oral medications 28, 29

Maximum Safe Frequency

• The British Thoracic Society states that there is no absolute maximum number of nebulizer treatments in 24 hours, but frequency should be titrated to clinical response in pediatric patients with acute severe asthma exacerbations 28, 29